Supraglottic Jet Oxygenation and Ventilation for Gastrointestinal Endoscopy at High-altitude
- Conditions
- High AltitudeHypoxia
- Interventions
- Procedure: Nasal cannula oxygen supplyProcedure: Supraglottic jet oxygenation and ventilation
- Registration Number
- NCT05304923
- Lead Sponsor
- Peking University People's Hospital
- Brief Summary
This study aims to determine whether the use of SOJV could reduce the rate of hypoxia during gastrointestinal endoscopic procedures in deeply sedated patients sedated at high altitude comparing to the supplemental oxygen administration via nasal cannula.
- Detailed Description
The participants will be randomly allocated to either SJOV or nasal cannula oxygen supply in a 1:1 ratio using block randomization with variable block sizes of four or six randomized. In the nasal cannula oxygen supply group, oxygen supplementation at 2 liters min-1 is delivered via a nasal cannula. In the SJOV group, SJOV is conducted using a Wei nasal jet tube (WNJ, Well Lead Medical Co. Ltd, Guangzhou, China) which is connected to a manual jet ventilator (Well Lead Medical Co. Ltd, Guangzhou, China) via its jet port.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 72
- 18 years or older;
- underwent routine gastrointestinal endoscopy under procedural sedation;
- consented to participate in this trial. -
- infection of the upper airway;
- anatomical abnormalities of the face, nose, and upper airway;
- coagulopathies;
- anticipated or known difficult airway;
- known allergy against propofol, soybeans, and egg;
- absence from the high-altitude environment during the past 3 months. -
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description nasal cannula oxygen supply Nasal cannula oxygen supply Oxygen supplementation is delivered via a nasal cannula to the participants during sedation. Supraglottic jet oxygenation and ventilation Supraglottic jet oxygenation and ventilation Supraglottic jet oxygenation and ventilation is conducted for the participants during sedation.
- Primary Outcome Measures
Name Time Method Hypoxia during sedation During sedation procedure An SPO2 of 75 - 89% for \< 60 s
- Secondary Outcome Measures
Name Time Method respiratory-related complications During sedation procedure pulmonary aspiration, respiratory depression (SPO2 = 90-95%) and severe hypoxia (SPO2 \< 75% or \< 90% for \> 60s)
cardiovascular-related complications During sedation procedure hypotension (systolic blood pressure \< 90 mmHg), hypertension (systolic blood pressure \> 160 mmHg), bradycardia (heart rate \< 50 beats/min), tachycardia (heart rate \> 120 beats/min)
fatal complications from sedation initiation to 20 min after patients are awake severe anaphylactic reactions, myocardial infarction, cardiac arrest and death
Trial Locations
- Locations (1)
Tibet autonomous region people's hospital
🇨🇳Lhasa, Tibet, China